Macrophage-Derived Inflammation Induces a Transcriptome Makeover in Mesenchymal Stromal Cells Enhancing Their Potential for Tissue Repair

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jan 20

PMID 33466704

Citations 8

Authors

Ines Maldonado-Lasuncion

Nick ONeill

Oliver Umland

Joost Verhaagen

Martin Oudega

Affiliations

Soon will be listed here.

Abstract

Pre-clinical and clinical studies revealed that mesenchymal stromal cell (MSC) transplants elicit tissue repair. Conditioning MSC prior to transplantation may boost their ability to support repair. We investigated macrophage-derived inflammation as a means to condition MSC by comprehensively analyzing their transcriptome and secretome. Conditioning MSC with macrophage-derived inflammation resulted in 3208 differentially expressed genes, which were annotated with significantly enriched GO terms for 1085 biological processes, 85 cellular components, and 79 molecular functions. Inflammation-mediated conditioning increased the secretion of growth factors that are key for tissue repair, including vascular endothelial growth factor, hepatocyte growth factor, nerve growth factor and glial-derived neurotrophic factor. Furthermore, we found that inflammation-mediated conditioning induces transcriptomic changes that challenge the viability and mobility of MSC. Our data support the notion that macrophage-derived inflammation stimulates MSC to augment their paracrine repair-supporting activity. The results suggest that inflammatory pre-conditioning enhances the therapeutic potential of MSC transplants.

Citing Articles

Cobalt ions-derived nanoenzyme array for endosseous neural network reconstruction and osseointegration.

Cai X, Yu M, Li B, Zhang Y, Han Y Bioact Mater. 2024; 42:1-17.

PMID: 39246698 PMC: 11378756. DOI: 10.1016/j.bioactmat.2024.08.005.

Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review.

Przywara D, Petniak A, Gil-Kulik P Med Sci Monit. 2024; 30:e945331.

PMID: 39154207 PMC: 11340262. DOI: 10.12659/MSM.945331.

Extracellular vesicles modulate key signalling pathways in refractory wound healing.

Yang B, Lin Y, Huang Y, Zhu N, Shen Y Burns Trauma. 2023; 11:tkad039.

PMID: 38026441 PMC: 10654481. DOI: 10.1093/burnst/tkad039.

Macrophages-bone marrow mesenchymal stem cells crosstalk in bone healing.

Fan S, Sun X, Su C, Xue Y, Song X, Deng R Front Cell Dev Biol. 2023; 11:1193765.

PMID: 37427382 PMC: 10327485. DOI: 10.3389/fcell.2023.1193765.

Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated.

Li T, Yan Z, Fan Y, Fan X, Li A, Qi Z Front Cardiovasc Med. 2023; 9:1077290.

PMID: 36698953 PMC: 9868426. DOI: 10.3389/fcvm.2022.1077290.

References

Lutton C, Young Y, Williams R, Meedeniya A, Mackay-Sim A, Goss B . Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury. J Neurotrauma. 2011; 29(5):957-70. DOI: 10.1089/neu.2010.1423. View

Pittenger M, Discher D, Peault B, Phinney D, Hare J, Caplan A . Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019; 4:22. PMC: 6889290. DOI: 10.1038/s41536-019-0083-6. View

Le Blanc K, Mougiakakos D . Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012; 12(5):383-96. DOI: 10.1038/nri3209. View

Gensel J, Zhang B . Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015; 1619:1-11. DOI: 10.1016/j.brainres.2014.12.045. View

Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54(24):2277-86. PMC: 3580848. DOI: 10.1016/j.jacc.2009.06.055. View

Gulhati P, Bowen K, Liu J, Stevens P, Rychahou P, Chen M . mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res. 2011; 71(9):3246-56. PMC: 3085654. DOI: 10.1158/0008-5472.CAN-10-4058. View

Palazon A, Goldrath A, Nizet V, Johnson R . HIF transcription factors, inflammation, and immunity. Immunity. 2014; 41(4):518-28. PMC: 4346319. DOI: 10.1016/j.immuni.2014.09.008. View

Xin X, Yang S, Ingle G, Zlot C, RANGELL L, Kowalski J . Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol. 2001; 158(3):1111-20. PMC: 1850376. DOI: 10.1016/S0002-9440(10)64058-8. View

Crisostomo P, Wang Y, Markel T, Wang M, Lahm T, Meldrum D . Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008; 294(3):C675-82. DOI: 10.1152/ajpcell.00437.2007. View

10.

Valles G, Bensiamar F, Crespo L, Arruebo M, Vilaboa N, Saldana L . Topographical cues regulate the crosstalk between MSCs and macrophages. Biomaterials. 2014; 37:124-33. PMC: 4245715. DOI: 10.1016/j.biomaterials.2014.10.028. View

11.

Li J, Liang C, Yang K, Huang X, Han M, Li X . Specific ablation of CD4 T-cells promotes heart regeneration in juvenile mice. Theranostics. 2020; 10(18):8018-8035. PMC: 7381734. DOI: 10.7150/thno.42943. View

12.

Cheung T, Galleu A, von Bonin M, Bornhauser M, Dazzi F . Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity. Haematologica. 2019; 104(10):e438-e441. PMC: 6886441. DOI: 10.3324/haematol.2018.214767. View

13.

Cooke J . Inflammation and Its Role in Regeneration and Repair. Circ Res. 2019; 124(8):1166-1168. PMC: 6578588. DOI: 10.1161/CIRCRESAHA.118.314669. View

14.

Fathke C, Wilson L, Shah K, Kim B, Hocking A, Moon R . Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biol. 2006; 7:4. PMC: 1388211. DOI: 10.1186/1471-2121-7-4. View

15.

Guo Y, Yu Y, Hu S, Chen Y, Shen Z . The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 2020; 11(5):349. PMC: 7214402. DOI: 10.1038/s41419-020-2542-9. View

16.

Peng Y, Chen X, Zhang X, Huang K, Liu L, Li H . Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia. 2014; 29(3):636-46. DOI: 10.1038/leu.2014.225. View

17.

Holland J, Klaus A, Garratt A, Birchmeier W . Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013; 25(2):254-64. DOI: 10.1016/j.ceb.2013.01.004. View

18.

Herrmann M, Verrier S, Alini M . Strategies to Stimulate Mobilization and Homing of Endogenous Stem and Progenitor Cells for Bone Tissue Repair. Front Bioeng Biotechnol. 2015; 3:79. PMC: 4451737. DOI: 10.3389/fbioe.2015.00079. View

19.

Loebel C, Burdick J . Engineering Stem and Stromal Cell Therapies for Musculoskeletal Tissue Repair. Cell Stem Cell. 2018; 22(3):325-339. PMC: 5834383. DOI: 10.1016/j.stem.2018.01.014. View

20.

Lee J, Lee S, Youn Y, Ahn M, Kim J, Yoo B . A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J Korean Med Sci. 2014; 29(1):23-31. PMC: 3890472. DOI: 10.3346/jkms.2014.29.1.23. View